1-3 of 3
Gabriele Tolle
Close
Sort by
Journal Articles

The Favorable Effect of Activating NOTCH1 Receptor Mutations On Long Term Outcome in T-ALL Is Treatment Related and Can Be Separated From NOTCH Pathway Activation by FBXW7 Loss of Function.

Corinne Kox, Martin Zimmermann, PhD, Martin Stanulla, MD, Martin Schrappe, MD, Wolf-Dieter Ludwig, Rolf Koehler, PhD, Svenja Leible, Gabriele Tolle, Obul Reddy Bandapalli, Stephen Breit, Martina Ulrike Muckenthaler, Andreas Kulozik, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 908.
https://doi.org/10.1182/blood.V114.22.908.908
Published: 2009
Journal Articles

Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia

Clinical Trials & Observations
Stephen Breit, Martin Stanulla, Thomas Flohr, Martin Schrappe, Wolf-Dieter Ludwig, Gabriele Tolle, Margit Happich, Martina U. Muckenthaler, Andreas E. Kulozik
Journal: Blood
Blood (2006) 108 (4): 1151–1157.
https://doi.org/10.1182/blood-2005-12-4956
Published: 2006
Includes: Supplemental data
Journal Articles

Activating NOTCH1 Mutations Are Associated with Good Treatment Response in Childhood T-Cell Acute Lymphoblastic Leukemia.

Stephen Breit, PhD, Martin Stanulla, MD, Thomas Flohr, PhD, Martin Schrappe, MD, Wolf-Dieter Ludwig, MD, Gabriele Tolle, Margit Happich, Martina M. Muckenthaler, PhD, Andreas E. Kulozik, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1444.
https://doi.org/10.1182/blood.V106.11.1444.1444
Published: 2005